Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR)

CUSIP: 71716E105

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Ordinary Shares / American Depositary Shares
Shares outstanding
705,983,417
Total 13F shares
59,127
Share change
+131
Total reported value
$857,346
Price per share
$14.50
Number of holders
8
Value change
+$1,902
Number of buys
4
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 71716E105?
CUSIP 71716E105 identifies PHAR - Pharming Group N.V. - Ordinary Shares / American Depositary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR) as of Q3 2025

As of 30 Sep 2025, Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 59,127 shares. The largest 8 holders included Silverberg Bernstein Capital Management LLC, MORGAN STANLEY, EverSource Wealth Advisors, LLC, Nalls Sherbakoff Group, LLC, NewEdge Advisors, LLC, BNP PARIBAS FINANCIAL MARKETS, Global Retirement Partners, LLC, and SBI Securities Co., Ltd.. This page lists 8 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.